Effectiveness of Clinic-Based Patient-Led Human Papilloma-virus DNA Self-Sampling Among HIV-Infected Women in Uganda.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310623752472

Enrollment

Registered

2023-10-25

Start date

2022-01-12

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer HIV/AIDS Humanpapilloma virus

Interventions

Clinic based HPV self sampling approach

Home based HPV selfsampling

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The study team approached and enrolled all HIV-infected women; • Not pregnant • Not in menstrual periods • Aged 25 to 49 years who have never been screened • Not screened within the last year (those who have screened for more than 1 year with normal results) • Have abnormal screening results • Attending the HIV clinic • Have provided informed consent to them to participate in the study.

Exclusion criteria

Exclusion criteria: All women who were critically ill and declined to participate in the study were excluded.

Design outcomes

Primary

Measure	Time frame
Continuation rate for HPV self-sampling.	—

Secondary

Measure	Time frame
Cost-effectiveness of clinic-based HPV self-sampling	—

Countries

Uganda

Contacts

Public ContactHellen Opolot

Executive Director

uncstresearch@uncst.go.ug+256414705525

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026